We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

Back to rankings

265 hedge funds and large institutions have $997M invested in Avanos Medical in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $541K | Put options by funds: $118K

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

13% more capital invested

Capital invested by funds: $884M → $997M (+$113M)

2.49% more ownership

Funds ownership: 93.14% → 95.63% (+2.5%)

2% more funds holding

Funds holding: 260 → 265 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 78

Holders
265
Holders Change
+5
Holders Change %
+1.92%
% of All Funds
3.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
41
Increased
67
Reduced
78
Closed
35
Calls
$541K
Puts
$118K
Net Calls
+$423K
Net Calls Change
+$438K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.1M
2
BlackRock
BlackRock
New York
+$6.77M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$4.72M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.66M
5
RC
RGM Capital
Florida
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
PIM
Paradice Investment Management
Colorado
-$12.8M
2
HA
Heartland Advisors
Wisconsin
-$3.76M
3
Invesco
Invesco
Georgia
-$2.54M
4
ECM
ExodusPoint Capital Management
New York
-$1.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$7.24M +$305K +14,784 +5%
Norges Bank
27
Norges Bank
Norway
$7.02M -$899K -43,573 -12%
Invesco
28
Invesco
Georgia
$6.33M -$2.54M -123,215 -30%
Citadel Advisors
29
Citadel Advisors
Florida
$5.72M +$1.71M +82,726 +48%
Principal Financial Group
30
Principal Financial Group
Iowa
$5.68M -$134K -6,503 -3%
JGC
31
J. Goldman & Co
New York
$5.31M +$114K +5,522 +2%
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$5.06M +$4.66M +225,640 New
JP Morgan Chase
33
JP Morgan Chase
New York
$4.56M -$915K -44,311 -18%
EAM
34
Eagle Asset Management
Florida
$4.12M -$215K -10,419 -5%
EF
35
Empowered Funds
Pennsylvania
$3.68M +$305K +14,784 +10%
VOYA Investment Management
36
VOYA Investment Management
Georgia
$3.67M -$1.14M -55,452 -25%
Legal & General Group
37
Legal & General Group
United Kingdom
$3.6M -$366K -17,753 -10%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$3.5M +$7.58K +367 +0.2%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$3.39M -$286K -13,856 -8%
JAM
40
Jupiter Asset Management
United Kingdom
$3.38M +$10.9K +526 +0.4%
KIM
41
Kestrel Investment Management
California
$3.27M +$3M +145,550 New
Two Sigma Advisers
42
Two Sigma Advisers
New York
$3.15M -$780K -37,800 -21%
Ohio Public Employees Retirement System (OPERS)
43
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.13M +$279K +13,538 +11%
N
44
Nuveen
North Carolina
$2.88M +$25.2K +1,219 +1%
ICM
45
Invenomic Capital Management
Massachusetts
$2.68M -$750K -36,331 -23%
Millennium Management
46
Millennium Management
New York
$2.64M +$1.6M +77,590 +194%
Victory Capital Management
47
Victory Capital Management
Texas
$2.43M -$298K -14,434 -12%
Envestnet Asset Management
48
Envestnet Asset Management
Illinois
$2.43M +$5.95K +288 +0.3%
AQR Capital Management
49
AQR Capital Management
Connecticut
$2.33M -$599K -29,005 -22%
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$2.32M +$623K +30,203 +41%
1
2
3 4 5

AVNS Hedge Fund Activity: Q4 2023 in Review

265 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2023, worth a combined $997M — up 13% from $884M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new AVNS positions and 35 closed out — a net gain of 6 holders — while 67 added to existing stakes and 78 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.1M. The largest seller was Paradice Investment Management, cutting an estimated $12.8M.

  • 265 institutional investors held Avanos Medical (AVNS) as of Q4 2023, up from 260 in Q3 2023.
  • Funds reported $997M of Avanos Medical stock for Q4 2023, up 13% quarter-over-quarter.
  • 41 funds opened new Avanos Medical positions in Q4 2023 and 35 closed out, a net change of +6 holders.
  • The largest Avanos Medical buyer in Q4 2023 was Morgan Stanley, an estimated $10.1M added.
  • The largest Avanos Medical seller in Q4 2023 was Paradice Investment Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2023.